TMC Life Sciences Berhad

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022🗂️ Report periods on file: 2022

In its 2022 reporting, TMC Life Sciences Berhad disclosed greenhouse gas emissions of 11.19 tCO2e (Scope 1) and 8,695.29 tCO2e (Scope 2). By scope: Scope 1: 11.19 tCO2e/year; Scope 2: 8.7K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
11.19 tCO2e (Scope 1) and 8,695.29 tCO2e (Scope 2)
2022
♻️
Waste
103.52 tons/year (hazardous)
2022
⚙️
Energy Use
13.7M kWh/year
2022

📊 Emissions by Scope (2022)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).11.19 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.8.7K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Obtain MSQH and ACHS accreditations.

📅 Medium-term

  • Complete Thomson Iskandar Medical Hub within 12-24 months after RTS completion.

🌱 ESG Focus Areas

Environmental SustainabilityCommunity OutreachPatient CareOrganisational Management

⚠️ Challenges & Risks +

  • COVID-19 pandemic impact on patient load and elective procedures.
  • Lagging recovery in medical tourism patients.
  • Challenges in recruiting and retaining healthcare professionals.
  • Global supply chain disruptions and inflationary pressures.
  • Increased competition in the fertility and TCM sectors.

📋 Report Information

Reporting Period: 2022
Frameworks: GRI Standards